| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
|
Landi, Lorenza
|
|
2014
|
15 |
6 |
p. 411-417.e4
4.16959E6 p.
|
artikel
|
| 2 |
Association Between Baseline Pulmonary Status and Interstitial Lung Disease in Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib—A Cohort Study
|
Johkoh, Takeshi
|
|
2014
|
15 |
6 |
p. 448-454
7 p.
|
artikel
|
| 3 |
Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients
|
Powrózek, Tomasz
|
|
2014
|
15 |
6 |
p. 455-465
11 p.
|
artikel
|
| 4 |
Diagnosis and Predictive Molecular Analysis of Non–Small-Cell Lung Cancer in the Africa-Middle East Region: Challenges and Strategies for Improvement
|
Slavik, Tomas
|
|
2014
|
15 |
6 |
p. 398-404
7 p.
|
artikel
|
| 5 |
Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series
|
Chiari, Rita
|
|
2014
|
15 |
6 |
p. 470-474
5 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2014
|
15 |
6 |
p. A6-
1 p.
|
artikel
|
| 7 |
Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway
|
Kris, Mark G.
|
|
2014
|
15 |
6 |
p. 475-
1 p.
|
artikel
|
| 8 |
Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Pujol, Jean-Louis
|
|
2014
|
15 |
6 |
p. 418-425
8 p.
|
artikel
|
| 9 |
nab-Paclitaxel for the Treatment of Advanced Squamous Non–Small-Cell Lung Cancer: A Comprehensive Update
|
Simon, George R.
|
|
2014
|
15 |
6 |
p. 391-397
7 p.
|
artikel
|
| 10 |
Occult Nodal Disease in Patients With Non–Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation
|
Robson, Jonathan M.
|
|
2014
|
15 |
6 |
p. 466-469
4 p.
|
artikel
|
| 11 |
Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
|
Chaft, Jamie E.
|
|
2014
|
15 |
6 |
p. 405-410
6 p.
|
artikel
|
| 12 |
Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer
|
Woodard, Gavitt A.
|
|
2014
|
15 |
6 |
p. 426-432
7 p.
|
artikel
|
| 13 |
Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non–Small-Cell Lung Cancer
|
He, Yan-yan
|
|
2014
|
15 |
6 |
p. 441-447
7 p.
|
artikel
|
| 14 |
Strategies to Prevent Brain Metastasis in High-Risk Non–Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation
|
Boggs, D. Hunter
|
|
2014
|
15 |
6 |
p. 433-440
8 p.
|
artikel
|
| 15 |
Table of Contents
|
|
|
2014
|
15 |
6 |
p. A8-
1 p.
|
artikel
|
Tijdschrift beschrijving